Related Experiment Videos
Obstructive left ventricular hypertrophy. Reversibility of outflow tract obstruction by drug therapy
N M Wheeldon1, T H Pringle, B J Lipworth
1Department of Cardiology, Ninewells Hospital and Medical School, Dundee.
Insights
This study identifies dynamic left ventricular outflow tract obstruction in patients with secondary left ventricular hypertrophy. Treatment with beta-blockers or calcium antagonists significantly improved symptoms and cardiac function.
Area of Science:
- Cardiology
- Medical Imaging
- Pharmacology
Background:
- Secondary left ventricular hypertrophy can arise from conditions like hypertension and aortic stenosis.
- Doppler echocardiography is a key diagnostic tool in cardiovascular assessment.
- Diastolic dysfunction is a common complication of left ventricular hypertrophy.
Observation:
- Four patients with secondary left ventricular hypertrophy presented with dynamic left ventricular outflow tract obstruction.
- These patients also exhibited significant impairment in diastolic filling.
- Symptoms were markedly improved in all patients following treatment.
Findings:
- Treatment with beta-blockers (atenolol) or calcium antagonists (verapamil) led to significant symptomatic benefit.
- Repeat Doppler studies demonstrated substantial improvements in both systolic and diastolic flow abnormalities.
- Dynamic left ventricular outflow tract obstruction is a recognizable entity in this patient subgroup.
Implications:
- Doppler echocardiography should be utilized to screen for left ventricular outflow tract obstruction in secondary left ventricular hypertrophy.
- Beta-blockers and rate-limiting calcium antagonists are effective therapeutic agents for this condition.
- Early recognition and targeted therapy can improve patient outcomes and cardiac function.
Abstract:
We report the cases of four patients with secondary left ventricular hypertrophy (three due to hypertension and one to aortic stenosis) in whom Doppler echocardiography showed dynamic left ventricular outflow tract obstruction and marked impairment of diastolic filling. Each patient derived marked symptomatic benefit from treatment with either a beta-blocker (atenolol) or calcium antagonist (verapamil). Repeat Doppler studies in three patients revealed a substantial improvement in systolic and diastolic flow abnormalities. Ventricular outflow tract obstruction should be recognized as occurring in a subgroup of patients with secondary left ventricular hypertrophy, and its presence should be sought by Doppler echocardiography before embarking on therapy. Negatively inotropic or positively lusitropic agents such as beta-blockers and rate-limiting calcium antagonists appear to be logical therapy for this condition.